Solid Biosciences Inc (SLDB)
9.97
-0.13
(-1.29%)
USD |
NASDAQ |
May 06, 16:00
10.00
+0.04
(+0.35%)
After-Hours: 20:00
Solid Biosciences Max Drawdown (5Y): 99.61% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.61% |
March 31, 2024 | 99.61% |
February 29, 2024 | 99.61% |
January 31, 2024 | 99.61% |
December 31, 2023 | 99.61% |
November 30, 2023 | 99.61% |
October 31, 2023 | 99.61% |
September 30, 2023 | 99.53% |
August 31, 2023 | 99.53% |
July 31, 2023 | 99.53% |
June 30, 2023 | 99.53% |
May 31, 2023 | 99.53% |
April 30, 2023 | 99.53% |
March 31, 2023 | 99.53% |
February 28, 2023 | 99.32% |
January 31, 2023 | 99.32% |
December 31, 2022 | 99.32% |
November 30, 2022 | 99.21% |
October 31, 2022 | 99.21% |
September 30, 2022 | 99.17% |
August 31, 2022 | 99.17% |
July 31, 2022 | 99.17% |
June 30, 2022 | 99.17% |
May 31, 2022 | 99.17% |
April 30, 2022 | 98.92% |
Date | Value |
---|---|
March 31, 2022 | 98.56% |
February 28, 2022 | 98.42% |
January 31, 2022 | 97.81% |
December 31, 2021 | 96.73% |
November 30, 2021 | 96.62% |
October 31, 2021 | 96.40% |
September 30, 2021 | 96.09% |
August 31, 2021 | 96.09% |
July 31, 2021 | 96.09% |
June 30, 2021 | 96.09% |
May 31, 2021 | 96.09% |
April 30, 2021 | 96.09% |
March 31, 2021 | 96.09% |
February 28, 2021 | 96.09% |
January 31, 2021 | 96.09% |
December 31, 2020 | 96.09% |
November 30, 2020 | 96.09% |
October 31, 2020 | 96.09% |
September 30, 2020 | 96.09% |
August 31, 2020 | 95.94% |
July 31, 2020 | 95.94% |
June 30, 2020 | 95.94% |
May 31, 2020 | 95.94% |
April 30, 2020 | 95.94% |
March 31, 2020 | 95.53% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
89.92%
Minimum
May 2019
99.61%
Maximum
Oct 2023
97.00%
Average
96.51%
Median
Max Drawdown (5Y) Benchmarks
Sarepta Therapeutics Inc | 64.93% |
PTC Therapeutics Inc | 73.78% |
Capricor Therapeutics Inc | 98.99% |
Perspective Therapeutics Inc | 91.70% |
Electromed Inc | 55.84% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -66.63 |
Beta (5Y) | 2.018 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 116.2% |
Historical Sharpe Ratio (5Y) | -0.3798 |
Historical Sortino (5Y) | -0.8843 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.74% |